{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:10:18Z","timestamp":1785769818134,"version":"3.56.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,10]]},"abstract":"<jats:p>This study aimed to retrospectively analyze the demographic data, presenting complaints, physical examination, echocardiographic and radiologic findings, treatments, and clinical course of 12 patients who were admitted to the Department of Pediatric Cardiology and diagnosed with Marfan syndrome (MS) according to the Ghent criteria between January 2017 and July 2023, in order to determine the importance of structural heart disease, accompanying findings, and duration of illness from diagnosis. In total, 9 of the 12 patients were male, 3 were female, and their ages ranged between 18 months and 17 years (10.6\u2005\u00b1\u20055.1 years). The median duration of illness from diagnosis was 36 months (12\u2013120 months) in all patients. When cardiovascular findings were analyzed, 6 (50%) of the patients had aortic root dilatation. All of these patients had aortic root dilation accompanied by mitral valve prolapse and mitral regurgitation (MR). Three of them also had tricuspid valve prolapse and moderate tricuspid regurgitation. Three other patients had mitral valve prolapse and mild MR, and 1 patient had only aortic regurgitation. This is due to aortic valve leaflet prolapse or elongation resulting from intrinsic connective tissue weakness, which disrupts diastolic coaptation. Echocardiographic examination was normal in 2 patients. Among the patients with severe aortic root dilation and severe MR, 2 patients underwent valve-sparing aortic root replacement surgery, and surgery was decided for the other patient. A total of 4 patients with severe aortic root dilation, including these 3, were clinically monitored with angiotensin receptor blockers, beta-blockers, and angiotensin-converting enzyme inhibitors. Patients with MS have significant structural heart disease. Since the incidence of skeletal system and ocular findings increases, especially in patients with aortic root dilatation, regular multidisciplinary follow-up of the patients in related specialties is extremely important.<\/jats:p>","DOI":"10.1097\/md.0000000000048299","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:01:29Z","timestamp":1775840489000},"page":"e48299","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Marfan syndrome and cardiovascular findings in children"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5366-647X","authenticated-orcid":false,"given":"Emine","family":"Yurdakul Ert\u00fcrk","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Ordu University, Ordu, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taner","family":"Kasar","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, Faculty of Medicine, Ordu University, Ordu, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260410","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(05)67789-6","article-title":"Marfan\u2019s syndrome.","volume":"366","author":"Judge","year":"2005","journal-title":"Lancet"},{"key":"R2-20260410","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R","article-title":"Revised diagnostic criteria for the Marfan syndrome.","volume":"62","author":"De Paepe","year":"1996","journal-title":"Am J Med Genet"},{"key":"R3-20260410","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jmg.2009.072785","article-title":"The revised Ghent nosology for the Marfan syndrome.","volume":"47","author":"Loeys","year":"2010","journal-title":"J Med Genet"},{"key":"R4-20260410","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1542\/peds.2008-0703","article-title":"Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations.","volume":"123","author":"Faivre","year":"2009","journal-title":"Pediatrics"},{"key":"R5-20260410","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cpcardiol.2007.10.001","article-title":"Marfan syndrome: diagnosis and management.","volume":"33","author":"Ammash","year":"2008","journal-title":"Curr Probl Cardiol"},{"key":"R6-20260410","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJM199405123301902","article-title":"Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan\u2019s syndrome.","volume":"330","author":"Shores","year":"1994","journal-title":"N Engl J Med"},{"key":"R7-20260410","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan\u2019s syndrome.","volume":"358","author":"Brooke","year":"2008","journal-title":"N Engl J Med"},{"key":"R8-20260410","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41572-021-00298-7","article-title":"Marfan syndrome.","volume":"7","author":"Milewicz","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R9-20260410","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/CIRCULATIONAHA.108.783753","article-title":"Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation working group on research in Marfan syndrome and related disorders.","volume":"118","author":"Pearson","year":"2008","journal-title":"Circulation"},{"key":"R10-20260410","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ajmg.1320290316","article-title":"International nosology of heritable disorders of connective tissue, Berlin.","volume":"29","author":"Beighton","year":"1986","journal-title":"Am J Med Genet"},{"key":"R11-20260410","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/01.CIR.80.4.915","article-title":"Mitral valve dimensions and motion in Marfan patients with and without mitral valve prolapse: comparison to primary mitral valve pro lapse and normal subjects.","volume":"80","author":"Pini","year":"1989","journal-title":"Circulation"},{"key":"R12-20260410","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.amjcard.2010.08.070","article-title":"Predictors of outcome of mitral valve prolapse in patients with the Marfan syndrome.","volume":"107","author":"Rybczynski","year":"2011","journal-title":"Am J Cardiol"},{"key":"R13-20260410","first-page":"11","article-title":"Marfan syndrome: current and future clinical and genetic management of cardiovascular manifestations.","volume":"5","author":"Pyeritz","year":"1993","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"R14-20260410","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.3390\/jcm8122079","article-title":"Case-matched comparison of cardiovascular outcome in Loeys-Dietz syndrome versus Marfan syndrome.","volume":"8","author":"Muhlstadt","year":"2019","journal-title":"J Clin Med"},{"key":"R15-20260410","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00246-012-0593-0","article-title":"Impact of age and gender on cardiac pathology in children and adolescents with Marfan syndrome.","volume":"34","author":"Mueller","year":"2013","journal-title":"Pediatr Cardiol"},{"key":"R16-20260410","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.echo.2013.02.018","article-title":"Echocardiographic methods, quality review, and measurement accuracy in a randomized multicenter clinical trial of Marfan syndrome.","volume":"26","author":"Selamet Tierney","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"key":"R17-20260410","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ahj.2013.02.019","article-title":"Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapy.","volume":"165","author":"Lacro","year":"2013","journal-title":"Am Heart J"},{"key":"R18-20260410","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3345\/kjp.2016.59.2.59","article-title":"Infantile Marfan syndrome in a Korean tertiary referral center.","volume":"59","author":"Seo","year":"2016","journal-title":"Korean J Pediatr"},{"key":"R19-20260410","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1253\/circj.CJ-11-0277","article-title":"Prevalence and correlates of physiological valvular regurgitation in healthy subjects.","volume":"75","author":"Okura","year":"2011","journal-title":"Circ J"},{"key":"R20-20260410","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/jmg.2007.056382","article-title":"Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1,009 probands.","volume":"45","author":"Faivre","year":"2008","journal-title":"J Med Genet"},{"key":"R21-20260410","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/hrt.79.1.69","article-title":"Marfan syndrome in children and adolescents: an adjusted nomogram for screening aortic root dilatation.","volume":"79","author":"Rozendaal","year":"1998","journal-title":"Heart"},{"key":"R22-20260410","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/heartjnl-2013-304920","article-title":"Aortic dilatation patterns and rates in adults with bicuspid aortic valves: a comparative study With Marfan syndrome and degenerative aortoppathy.","volume":"100","author":"Detaint","year":"2014","journal-title":"Heart"},{"key":"R23-20260410","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1086\/520125","article-title":"Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study.","volume":"81","author":"Faivre","year":"2007","journal-title":"Am J Hum Genet"},{"key":"R24-20260410","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.acvd.2019.09.010","article-title":"Incidence of cardiovascular events and risk markers in a prospective study of children diagnosed with Marfan syndrome.","volume":"113","author":"Hascoet","year":"2020","journal-title":"Arch. Cardiovasc Dis"},{"key":"R25-20260410","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/CIRCULATIONAHA.115.017202","article-title":"Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre.","volume":"132","author":"Diller","year":"2015","journal-title":"Circulation"},{"key":"R26-20260410","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.athoracsur.2007.01.018","article-title":"Orthotopic heart transplantation in patients with Marfan syndrome.","volume":"83","author":"Knosalla","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"R27-20260410","doi-asserted-by":"crossref","first-page":"bcr2015211138","DOI":"10.1136\/bcr-2015-211138","article-title":"Type B aortic dissection triggered by heart transplantation in a patient with Marfan syndrome.","volume":"2015","author":"Audenaert","year":"2015","journal-title":"BMJ Case Rep"},{"key":"R28-20260410","doi-asserted-by":"crossref","first-page":"e81281","DOI":"10.1371\/journal.pone.0081281","article-title":"Observational cohort study of ventricular arrhythmia in adults with Marfan syndrome caused by FBN1 mutations.","volume":"8","author":"Aydin","year":"2013","journal-title":"PLoS One"},{"key":"R29-20260410","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.ijcard.2012.06.036","article-title":"Prospective risk stratification of sudden cardiac death in Marfan\u2019s syndrome.","volume":"167","author":"Hoffmann","year":"2013","journal-title":"Int J Cardiol"},{"key":"R30-20260410","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0735-1097(02)02699-2","article-title":"Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death?","volume":"41","author":"Yetman","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R31-20260410","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJM197204132861502","article-title":"Life expectancy and causes of death in the Marfan syndrome.","volume":"286","author":"Murdoch","year":"1972","journal-title":"N Engl J Med"},{"key":"R32-20260410","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.CIR.11.3.321","article-title":"The cardiovascular aspects of Marfan\u2019s syndrome: a heritable disorder of connective tissue.","volume":"11","author":"McKusick","year":"1955","journal-title":"Circulation"},{"key":"R33-20260410","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.amjcard.2006.08.048","article-title":"Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome.","volume":"99","author":"Ladouceur","year":"2007","journal-title":"Am J Cardiol"},{"key":"R34-20260410","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4236\/ojts.2014.42010","article-title":"Neonatal Marfan syndrome: improving the bad prognosis with a strict conservative treatment with carvedilol?","volume":"04","author":"Buchhorn","year":"2014","journal-title":"Open J Thorac Surg"},{"key":"R35-20260410","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","article-title":"Atenolol versus losartan in children and young adults with Marfan\u2019s syndrome.","volume":"371","author":"Lacro","year":"2014","journal-title":"N Engl J Med"},{"key":"R36-20260410","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1161\/CIRCULATIONAHA.107.693523","article-title":"Medical management of Marfan syndrome.","volume":"117","author":"Keane","year":"2008","journal-title":"Circulation"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:21:57Z","timestamp":1785766917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":36,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048299","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"2025-02-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}